Mast-Cell Leukemia

Mast-Cell Leukemia, also known as mast cell leukemia, is related to mastocytosis, cutaneous and aggressive systemic mastocytosis. An important gene associated with Mast-Cell Leukemia is KIT (KIT Proto-Oncogene, Receptor Tyrosine Kinase), and among its related pathways/superpathways are Innate Immune System and Signal Transduction. The drugs Lenograstim and Prednisolone have been mentioned in the context of this disorder. Affiliated tissues include myeloid and bone marrow, and related phenotypes are Decreased viability and Decreased substrate adherent cell growth